Literature DB >> 11829457

In vitro induction of bilirubin conjugation in primary rat hepatocyte culture.

Katalin Jemnitz1, György Lengyel, László Vereczkey.   

Abstract

UDP-glucuronosyltransferase (UGT1A1) is a critical enzyme in the elimination of bilirubin. The aim of our study was to investigate bilirubin conjugation in primary rat hepatocyte culture and the in vitro inducibility of this isoenzyme by inducing compounds of different classes: dexamethasone, clofibrate, rifampicin, and methylcholanthrene. Hepatocytes exhibited a marked decline in UGT1A1 activity in the first 4 h of culturing (10% of initial activity) and the recovery took 72 h. Immunoblot analysis proved that the loss of enzyme activity was associated with the decrease of protein concentration. Marked induction was detected in the cases of dexamethasone, clofibrate, and rifampicin treatments for 96 h both in enzyme activity (178, 176, and 168%) and in UGT1A1 protein level (362, 328, and 250%). The effects of dexamethasone and clofibrate were additive (210%). Methylcholanthrene had no influence on bilirubin conjugation in our system. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829457     DOI: 10.1006/bbrc.2002.6400

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.

Authors:  Wen Xie; Mei-Fei Yeuh; Anna Radominska-Pandya; Simrat P S Saini; Yoichi Negishi; Bobbie Sue Bottroff; Geraldine Y Cabrera; Robert H Tukey; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

2.  A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors.

Authors:  Suzanne F Jones; Lillian L Siu; Johanna C Bendell; James M Cleary; Albiruni R A Razak; Jeffrey R Infante; Shuchi S Pandya; Philippe L Bedard; Kristen J Pierce; Brett Houk; W Gregory Roberts; S Martin Shreeve; Geoffrey I Shapiro
Journal:  Invest New Drugs       Date:  2015-09-04       Impact factor: 3.850

3.  A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR.

Authors:  Wendong Huang; Jun Zhang; David D Moore
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 4.  The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions.

Authors:  Sara Correia Marques; Ogechi N Ikediobi
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

5.  Oleanolic Acid and Ursolic Acid Induce UGT1A1 Expression in HepG2 Cells by Activating PXR Rather Than CAR.

Authors:  Na Yao; Caiwen Zeng; Tao Zhan; Fang He; Mingyi Liu; Fanglan Liu; Hong Zhang; Yuqing Xiong; Chunhua Xia
Journal:  Front Pharmacol       Date:  2019-09-27       Impact factor: 5.810

Review 6.  Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.

Authors:  Jiezhong Chen; Kenneth Raymond
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-02-15       Impact factor: 3.944

7.  A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors.

Authors:  Toshio Shimizu; Kazuya Fukuoka; Masayuki Takeda; Tutomu Iwasa; Takeshi Yoshida; Joanna Horobin; Mitchell Keegan; Lou Vaickus; Ajit Chavan; Mahesh Padval; Kazuhiko Nakagawa
Journal:  Cancer Chemother Pharmacol       Date:  2016-03-30       Impact factor: 3.333

8.  Rifampin Reduces the Plasma Concentrations of Oral and Intravenous Hydromorphone in Healthy Volunteers.

Authors:  Terhi J Lohela; Satu Poikola; Mikko Neuvonen; Mikko Niemi; Janne T Backman; Klaus T Olkkola; Tuomas O Lilius
Journal:  Anesth Analg       Date:  2021-08-01       Impact factor: 6.627

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.